This is a Validated Antibody Database (VAD) review about human HLA-DQB2, based on 5 published articles (read how Labome selects the articles), using HLA-DQB2 antibody in all methods. It is aimed to help Labome visitors find the most suited HLA-DQB2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
HLA-DQB2 synonym: HLA-DQB1; HLA-DXB; HLA class II histocompatibility antigen, DQ beta 2 chain; DV19.1 (major histocompatibility complex, class II, DQ beta 2 (HLA-DXB)); HLA class II histocompatibility antigen, DX beta chain; MHC class II antigen DQB2
Miltenyi Biotec
human recombinant (REA332) |
| Miltenyi Biotec HLA-DQB2 antibody (Miltenyi Biotec, REA332) was used in flow cytometry on human samples (fig s3j). Biol Blood Marrow Transplant (2018) ncbi |
human recombinant (REA332) |
| Miltenyi Biotec HLA-DQB2 antibody (Miltenyi Biotec, REA332) was used in flow cytometry on human samples at 1:20 (fig 6a). J Immunol (2017) ncbi |
human recombinant (REA332) |
| In order to develop a recombinant Saccharomyces cerevisiae as a vehicle to deliver genes to primary human macrophages, Miltenyi Biotec HLA-DQB2 antibody (Miltenyi Biotec, REA332) was used in flow cytometry on human samples (fig 1a). Eur J Pharm Biopharm (2017) ncbi |
human recombinant (REA332) |
| In order to analyze how Saccharomyces cerevisiae interacts with different macrophage subsets, Miltenyi Biotec HLA-DQB2 antibody (Miltenyi Biotec, REA332) was used in flow cytometry on human samples (fig 1). Inflammation (2016) ncbi |
Santa Cruz Biotechnology
mouse monoclonal (B-K27) |
| Santa Cruz Biotechnology HLA-DQB2 antibody (SantaCruz, B-k-27) was used in western blot on human samples (fig 2a). Childs Nerv Syst (2017) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments